Search by Drug Name or NDC

    NDC 25021-0105-10 ceftriaxone 500 mg/1 Details

    ceftriaxone 500 mg/1

    ceftriaxone is a INTRAMUSCULAR; INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is CEFTRIAXONE SODIUM.

    Product Information

    NDC 25021-0105
    Product ID 25021-105_283f5a26-664b-4645-a203-20dc88b4b8df
    Associated GPIs 02300090102110
    GCN Sequence Number 009166
    GCN Sequence Number Description ceftriaxone sodium VIAL 500 MG INJECTION
    HIC3 W1Y
    HIC3 Description CEPHALOSPORIN ANTIBIOTICS - 3RD GENERATION
    GCN 39961
    HICL Sequence Number 003996
    HICL Sequence Number Description CEFTRIAXONE SODIUM
    Brand/Generic Generic
    Proprietary Name ceftriaxone
    Proprietary Name Suffix n/a
    Non-Proprietary Name ceftriaxone
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, FOR SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 500
    Active Ingredient Units mg/1
    Substance Name CEFTRIAXONE SODIUM
    Labeler Name Sagent Pharmaceuticals
    Pharmaceutical Class Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA065329
    Listing Certified Through 2023-12-31

    Package

    NDC 25021-0105-10 (25021010510)

    NDC Package Code 25021-105-10
    Billing NDC 25021010510
    Package 25 VIAL in 1 CARTON (25021-105-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
    Marketing Start Date 2009-11-05
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 5cf93bc5-9e4c-4734-bc02-c7d0ac071022 Details

    Revised: 2/2022